Posts

StromaForte by Swedish StromaBio for Ageing: Likelihood...

StromaForte is under clinical development by Swedish StromaBio and currently in ...

StromaForte by Swedish StromaBio for Osteoarthritis: Li...

StromaForte is under clinical development by Swedish StromaBio and currently in ...

STAT turns 8: A letter from the executive editor

Today STAT turns 8! Read a letter from our executive editor @rickberke on the mi...

STAT+: Senate bill would permanently extend Covid-era r...

A bipartisan bill would permanently extend a Covid-era policy that allowed patie...

STAT+: Novo Nordisk is concluding research on Wegovy’s ...

Want to stay on top of the science and politics driving biotech today? Sign up t...

High biological age may increase the risk of dementia a...

People who have a higher biological age than their actual chronological age have...

Medeor Therapeutics’ Innovative Kidney Transplant Cell ...

Medeor Therapeutics’ MDR-101 is a single-dose cell therapy designed to revolutio...

Kronos trims staff by 19% for phase 1/2 solid tumor drug

Kronos Bio, following promising outcomes in an initial evaluation of a phase 1/2...

AstraZeneca’s zibotentan granted new life in CKD trial

In a surprising turn of events, AstraZeneca’s once-forgotten drug, zibotentan, h...

D3L-001 by D3 Bio for Human Epidermal Growth Factor Rec...

D3L-001 is under clinical development by D3 Bio and currently in Phase I for Hum...

D3L-001 by D3 Bio for Gastroesophageal (GE) Junction Ca...

D3L-001 is under clinical development by D3 Bio and currently in Phase I for Gas...

RPA-601 by Rocket Pharmaceuticals for Cardiomyopathy: L...

RPA-601 is under clinical development by Rocket Pharmaceuticals and currently in...

Debio-4127 by Debiopharm International for Neuroendocri...

Debio-4127 is under clinical development by Debiopharm International and current...

HUC-3443 by Huons for Idiopathic (Essential) Hypertensi...

HUC-3443 is under clinical development by Huons and currently in Phase II for Id...

HUC-3443 by Huons for Hypercholesterolemia: Likelihood ...

HUC-3443 is under clinical development by Huons and currently in Phase II for Hy...

QL-325 by QLSF Biotherapeutics for Acute Myelocytic Leu...

QL-325 is under clinical development by QLSF Biotherapeutics and currently in Ph...